Women’s Reproductive Health: Key Challenges and Interventions

Reproductive health is far more than the absence of disease related to childbearing. The World Health Organization defines it as a state of complete physical, mental and social well-being in all matters relating to the reproductive system. For millions of women, however, this definition remains aspirational. Persistent gaps in contraceptive choice, unsafe pregnancies, and the rapid rise of new reproductive technologies have created a complex landscape where progress and inequality exist side by side. This post unpacks the most pressing challenges in women’s reproductive health and the interventions shaping the road ahead.

Contraception and family planning: choice, access, and consequences 🔗

Family planning is the cornerstone of reproductive autonomy. It allows individuals to decide whether, when, and how many children to have. According to the National Family Health Survey (NFHS-5), the contraceptive prevalence rate among married women aged 15-49 stands at 66.7%, with modern method use at 56.5%. While these numbers represent significant progress, the deeper story lies in which methods women use and why.

Temporary methods: pills, condoms, IUDs, and injectables 🔗

Temporary contraceptives include oral contraceptive pills, male and female condoms, intrauterine contraceptive devices (IUCDs), injectables like DMPA, and the relatively newer Antara programme. These methods offer reversible birth control and allow women to space pregnancies safely. A study based on NFHS-5 data found that utilization of temporary contraception among reproductive-aged women is around 66.1%, with usage varying widely across states.

However, temporary methods come with concerns. Hormonal pills can cause nausea, weight changes, mood disturbances, and increased risk of blood clots in some users. IUDs sometimes cause cramping or heavier menstrual bleeding. Injectables may delay return to fertility. Many women discontinue these methods because of side effects, fear, or lack of follow-up counselling, leading to unintended pregnancies.

Permanent methods: the sterilization imbalance 🔗

Female sterilization remains the dominant contraceptive method, accounting for the largest share of modern method use in the country. In contrast, male sterilization (vasectomy) remains negligible, at well under 1% of contraceptive use. This skewed pattern persists despite vasectomy being a simpler, safer, and less invasive procedure than tubectomy.

The roots of this imbalance are historical and cultural. As one analysis notes, aggressive male sterilization campaigns during the Emergency era stigmatized the procedure and shifted the burden disproportionately onto women. Even today, the cultural assumption that contraception is a “women’s responsibility” prevents many couples from considering vasectomy.

Barriers to access 🔗

Access remains uneven across regions, classes, and communities. Rural women, adolescents, unmarried women, and women from marginalized castes and tribes face the steepest barriers. Common obstacles include the cost of private services, stigma around seeking contraception (particularly for unmarried women), inadequate counselling at primary health centres, stock-outs of preferred methods, and provider bias that pushes women toward sterilization rather than reversible methods.

Barriers to safe motherhood 🔗

Safe motherhood means ensuring that every pregnancy and childbirth is healthy and free of preventable risk. India has made remarkable progress here, but maternal mortality and morbidity remain unfinished agendas.

Maternal mortality: progress with persistent gaps 🔗

India’s maternal mortality ratio (MMR) has declined dramatically over two decades. According to research based on nationally representative data, the MMR fell by about 70%, from 398 per 100,000 live births in 1997-98 to around 99 per 100,000 by 2020. The latest Sample Registration System data places the figure at 97 per 100,000 live births, putting the country within reach of the Sustainable Development Goal target of fewer than 70 by 2030.

But national averages hide stark inequalities. States like Kerala and Andhra Pradesh report MMRs around 30, while states such as Assam, Madhya Pradesh, Uttar Pradesh, and Odisha lag significantly behind. As data from a major analysis shows, around 22,500 women still die from maternal causes every year, with most deaths concentrated in poorer states and among women aged 20-29.

Antenatal care: the missing link 🔗

Antenatal care (ANC) is a critical intervention. The Ministry of Health recommends at least four ANC visits, but the WHO now suggests eight contacts. ANC enables early detection of conditions like anaemia, hypertension, gestational diabetes, and fetal abnormalities. It also offers iron-folic acid supplementation, tetanus immunisation, and counselling on nutrition and danger signs.

Despite government schemes such as Pradhan Mantri Surakshit Matritva Abhiyan, ANC coverage remains incomplete. Many rural and tribal women receive fewer than the recommended visits, and the quality of these visits is often poor. Anaemia is particularly endemic. NFHS-5 reports that more than half of pregnant women suffer from anaemia, a key contributor to maternal haemorrhage, which is itself the leading cause of maternal death.

Unsafe abortions 🔗

Although abortion has been legal since 1971 under the Medical Termination of Pregnancy (MTP) Act, unsafe abortion remains a major contributor to maternal mortality. The MTP (Amendment) Act, 2021 extended the upper gestational limit to 24 weeks for specific categories of women and broadened the grounds for legal termination.

Even so, many women still rely on untrained providers or self-administer abortion pills bought without medical supervision. A clinical study highlighted that unsupervised medication-induced abortions are linked to higher rates of incomplete abortion, haemorrhage, and infection. The reasons are familiar: stigma, lack of confidentiality at public facilities, limited awareness of legal rights, and a shortage of trained providers in rural areas. Sex-selective abortion, although banned under the PCPNDT Act, also continues to distort the sex ratio in several regions.

Emerging reproductive technologies and their implications 🔗

The last three decades have witnessed an explosion of new reproductive technologies (NRTs) – from in-vitro fertilization (IVF) and intrauterine insemination (IUI) to surrogacy, oocyte donation, embryo freezing, and pre-implantation genetic diagnosis. For couples facing infertility, these technologies have been life-changing. India’s infertility burden is substantial: estimates suggest that primary infertility prevalence in the country ranges between 3.9% and 16.8%, and the assisted reproductive technology market is rapidly expanding.

Medical and health implications 🔗

NRTs are not risk-free. Ovarian hyperstimulation syndrome, multiple pregnancies, preterm births, and low birth weight are documented risks. Repeated hormone treatments can have long-term effects that are still under study. Surrogate mothers, in particular, face risks of gestational diabetes, pre-eclampsia, and cesarean complications. There is also limited long-term data on the health of children born through some ART procedures.

Ethical concerns 🔗

NRTs raise difficult ethical questions. Pre-implantation genetic diagnosis can be used to screen out genetic disorders, but it can also enable selective reproduction based on traits – including sex, which is prohibited in India but remains a concern. Commercial surrogacy, before its ban, drew criticism for commodifying women’s bodies and exploiting economically vulnerable women who served as gestational carriers for wealthy couples, often from abroad.

The regulatory framework 🔗

India has responded with two major laws. The Assisted Reproductive Technology (Regulation) Act, 2021 sets standards for ART clinics and banks, mandates registration, and regulates the use of gametes and embryos. The Surrogacy (Regulation) Act, 2021 prohibits commercial surrogacy and permits only altruistic surrogacy under tightly defined conditions.

Critics, however, argue that the laws are exclusionary. As legal scholars point out, the surrogacy framework allows only heterosexual married couples to access these services and excludes single women, widows, LGBTQ+ individuals, and live-in partners, even when they desire children but cannot conceive. The altruistic-only model has also been criticised for denying surrogates fair compensation for their reproductive labour while still expecting them to bear the physical and emotional burden of pregnancy.

Social implications 🔗

NRTs are expensive. A single IVF cycle in a private clinic can cost between ₹1.5 lakh and ₹3 lakh, putting it out of reach for most lower- and middle-income families. This creates a two-tier system in which wealthy couples can access cutting-edge fertility treatments while poorer women struggle even to access basic antenatal care. The cultural pressure on women to bear children – particularly sons – also pushes many into repeated cycles of NRT use, often at significant emotional and financial cost.

Interventions and the road ahead 🔗

Improving women’s reproductive health requires action on multiple fronts. Strengthening primary healthcare, expanding the basket of contraceptive choices (especially reversible methods for younger women), training more skilled birth attendants, ensuring rights-based access to safe abortion, and regulating NRTs with an equity lens are all essential. Programmes like the Janani Suraksha Yojana and Janani Shishu Suraksha Karyakram have improved institutional delivery rates and reduced out-of-pocket expenses for poor women, but their impact on quality of care needs continuous monitoring.

Equally important is the cultural shift. Reproductive health cannot be improved without addressing gender norms that place the burden of contraception, childbearing, and fertility almost entirely on women. Engaging men, educating adolescents, and treating reproductive rights as fundamental rights – not welfare schemes – is the broader project that lies ahead.

What do you think? Why does the burden of contraception still fall so disproportionately on women in our society, and what would meaningful male participation in reproductive health look like? Should the regulation of new reproductive technologies prioritize protecting vulnerable women, or expanding access for all those who wish to become parents – and can these goals coexist?

References

1. https://www.who.int/health-topics/sexual-and-reproductive-health-and-rights
2. https://nhm.gov.in/index1.php?lang=1&level=2&sublinkid=821&lid=222
3. https://www.frontiersin.org/journals/global-womens-health/articles/10.3389/fgwh.2023.1219003/full
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC9292773/
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC12178503/
6. https://www.dataforindia.com/maternal-mortality/
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC10470576/
8. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12106933/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC10994889/
10. https://nhm.gov.in/